Quanticate Collecting, Analyzing and Reporting Clinical and Safety Data for Clinical and Post-Market Studies

Quanticate, with headquarters in the UK and the US, is a specialist clinical research organization (CRO) primarily focused on the management, analysis and reporting of data from clinical trials and post-marketing surveillance. We provide very efficient outsourcing solutions for companies who need additional capacity or who want to outsource certain functions in their entirety.

We deliver scalable on-site and off-site data management, statistical consultancy, statistical programming and analysis, medical writing and pharmacovigilance services. We also have a staff recruitment arm, ‘Quanticate People’, to help sponsors find all types of permanent and contract staff.

Clinical data management

Our data management team performs database build, data collection, data entry, query management, and coding of adverse event, medication and medical history data. We have extensive experience in helping our customers become CDISC compliant, and have undertaken numerous projects involving the migration of legacy data to CDISC standards. Quanticate uses whatever systems its customers prefer for EDC, clinical data management and ePRO and therefore has experience in many technologies.

Statistical consultancy services for clinical trials

We provide protocol development activities with input into the design considerations, statistical methodology to be used, as well as the sample size estimation. We will simulate the likely outcomes of the study under different scenarios.

Over the years many Adaptive Design and Bayesian methodologies have become widely used, but choosing the right ones at the right time is crucial to placing control over research programs at all stages of development. Quanticate consultants can help dispel some ‘myths’ and advise on the advantages and disadvantages of the different designs that you may be considering. Well-planned study designs ensure the best project go/no go decisions and lead to the earliest possible technical and regulatory success.

Services include producing a reporting and analysis plan, generating tables, listings and figures, performing statistical analysis, and providing DSMB support.

Statistical programming for clinical studies

Whether we are using our internal global macro library, a client’s internal environment, or developing customized software solutions, Quanticate programmers are industry leaders in providing validated results to clinical study reports and submission-ready deliverables. Quanticate has over 100 full-time programmers.

Medical writing consultancy

Quanticate’s medical writing services include clinical and regulatory writing as well as scientific communications, education material and medical writing consultancy. Our medical writers have a wide depth of knowledge and experience drawn from the pharmaceutical industry, contract research organizations and academic research. All documents produced by Quanticate undergo thorough scientific, statistical, editorial and quality control review.

Pharmacovigilance services

Quanticate offers a range of pharmacovigilance services throughout all phases of clinical development and post-marketing. There is advantage in centralizing all safety data, clinical data, analysis and reporting with one provider. By combining Quanticate’s substantial biometrics, medical writing and pharmacovigilance expertise, we offer a fully compliant and high-quality complete package of pharmacovigilance services.

Our goal is to help our customers meet strict regulatory requirements, along with managing the risk-benefit profile of products, in order to maximize product potential, whilst ensuring patient safety. From outsourcing of individual activities, to the set-up and management of an effective and efficient global pharmacovigilance system, Quanticate provides solutions specific to the requirements of our customer’s organization and products.

Project management services for clinical trials

A key element of successful project delivery is effective project management. Quanticate project managers offer each customer an accessible, single point of contact for project communication, timely delivery of milestones and budgetary control. Our project managers have extensive experience in managing projects on behalf of our customers, organizing and coordinating the efforts of both the customer and other CRO resources to ensure projects are delivered successfully.

Strategic resourcing for clinical trials

Quanticate is well known for its ability to provide dedicated teams of people such as SAS programmers, statisticians, data managers and medical writers. These teams are dedicated to a customer for a specified period of time. Sometimes referred to as Functional Service Provision (FSP), this solution gives sponsors an extension of their clinical team for as long as needed.

It usually involves Quanticate employees working from our own offices but connected to the sponsor’s IT infrastructure. We can also provide people to work on site. In addition to Quanticate employees, our solution can be augmented to include contractors or permanent staff placements provided through our recruitment business, Quanticate People.

Make an enquiry

Follow this company

Follow the company to be always up to date with this company

Press Release

Exclusive Cooperation Between ARTES and the Ukrainian National Academy of Sciences

ARTES has announced that it has signed an exclusive marketing agreement with the Institute of Cell Biology of the National Academy of Science of Ukraine. The agreement is that the NAS technology based on the yeast organism Hansenula polymorpha is now exclusively marketed and licensed by ARTES Bio

White Papers

Bayesian Study Design: The Pragmatic Solution for Phase II Clinical Development

Bayesian Study Design: The Pragmatic Solution for Phase II Clinical Development

Quanticate Images

Products and Services

Video

Press Release

8 March 2011

Fujifilm Corporation and Merck, known as MSD outside the US and Canada, have announced that they have entered into a definitive agreement by which Fujifilm will acquire the Merck BioManufacturing Network, a leading provider of contract manufacturing and development services for the biopharmaceut

Read more
26 September 2010

ARTES Biotechnology announces today the acquirement of the ANAVAX virus-like particle (VLP) technology from Select Vaccines. ANAVAX is a patent-protected VLP technology that can be applied to the prevention of several infectious diseases. With the combination of two excellent technolog

Read more
28 April 2010

Q Chip and ARTES Biotechnology have announced that they have signed a collaborative agreement to explore the co-development of a new sustained release formulation of interferon alpha 2a for the treatment of chronic hepatitis B and C. The study is designed to evaluate Q Chips' Q-Sphera&

Read more
16 November 2009

ARTES Biotechnology, specialised in recombinant protein production and process development from yeast expression systems, and Rhein Minapharm Biogenetics, a subsidiary of Minapharm SAE, jointly announced the successful production of a new target of a therapeutic protein. This was the first result

Read more
22 September 2009

Bachem is continuously expanding and updating its extensive range of products for your research purposes. We are pleased to present our latest product additions, which include a number of bioactive molecules, synthetic RANTES peptides, several LHRH impurities and a range of new immunology product

Read more
1 September 2009

ARTES Biotechnology has announced its collaboration with five other collaboration partners in a joint 28-month research programme that is granted by the national Deutsche Stiftung Umwelt within the ChemBioTec initiative. The Deutsche Bundesstiftung Umwelt DBU is one of Europe's largest foundation

Read more
5 August 2009

ARTES has announced that it has signed an exclusive marketing agreement with the Institute of Cell Biology of the National Academy of Science of Ukraine. The agreement is that the NAS technology based on the yeast organism Hansenula polymorpha is now exclusively marketed and licensed by ARTES Bio

Read more
10 May 2009

ARTES Biotechnology has announced its collaboration with Henkel in a joint three-year research programme that is granted by the German national BMBF (German Ministery of Education and Research) within the CLIB2021 cluster (Wettbewerb Industrielle Biotechnologie 2021). The cooperation aims to adva

Read more
29 May 2007

ACE Pharmaceuticals today announced that the first patient has entered the Phase III trial also known as the Levamisole trial. This trial was accepted by the EMEA by November 2006. The goal of this trial, which was accepted by the EMEA in November 2006, is to assess the efficacy and sa

Read more

Regional Offices

Quanticate Ltd

Bevan House

Bancroft Court

Hertfordshire SG5 1LH

Hitchin

Other

United Kingdom

+44 1462 440 084
Quanticate, Inc.

101 Main Street, Suite 1720

MA 02142

Cambridge

Other

United States of America

+1 857 998 6860
Quanticate, Inc.

Tokyo

Other

Japan

+81 3 6380 3998<br>Tel: +81 80 4070 3107

Contact company

I have read and accept the terms and conditions and privacy policy.
We'd like to keep you informed about relevant promotions, products and services, if you would like not to receive these, check this box.
If you would like to hear from carefully selected third party companies, check this box
Follow this company to receive notifications when they update.